Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
This research study is being conducted to compare the safety and effectiveness of the
investigational medication, LdT (telbivudine) versus adefovir dipivoxil, a drug approved by
the Food and Drug Administration (FDA) for the treatment of hepatitis B infection. The
results for patients taking LdT will be compared to results for patients taking adefovir
dipivoxil.